News
SNZZF
0.261
NaN%
--
Senzime Expands TetraGraph Use into Electroconvulsive Therapy
TipRanks · 11/05 08:32
Senzime AB Earnings Call Shows Profitable Growth Path
TipRanks · 11/01 00:06
Senzime AB (publ) GAAP EPS of -SEK0.07, revenue of TSEK30.09
Seeking Alpha · 10/29 17:46
Senzime Posts Strong Q3 Sensor Growth and Moves Closer to Profitability
TipRanks · 10/29 07:46
Senzime Schedules Webcast and Q&A for Q3 2026 Report
TipRanks · 10/26 08:32
Senzime Data at ANESTHESIOLOGY 2026 Bolsters Case for TetraGraph and Cost-Saving Monitoring
TipRanks · 10/17 17:32
Senzime Unveils Predictive Neuromuscular Monitoring Suite for TetraGraph
TipRanks · 10/13 13:03
Senzime Sticks to Q4 2026 Positive Cash Flow Target on Double-Digit Sales Growth
TipRanks · 10/05 14:32
ElevenLabs doubles valuation to $22B after recent $300M employee tender offer
Seeking Alpha · 09/30 18:37
Senzime Secures New Credit Facility to Drive OEM Expansion and Path to Profitability
TipRanks · 09/28 13:34
Senzime Wins Major US Hospital Network Deal for TetraGraph Monitors
TipRanks · 09/24 15:02
Senzime Wins Exclusive Five-Year VA Contract for TetraGraph Monitoring System
TipRanks · 08/05 07:35
Senzime AB (publ) reports Q2 results
Seeking Alpha · 07/16 11:11
Senzime Boosts Sensor Sales and Margins Despite U.S. Market Headwinds
TipRanks · 07/16 06:35
Senzime Strikes Landmark Global Patient Monitoring Partnership with Philips
TipRanks · 07/15 19:32
Senzime Sets Webcast and Q&A for Q2 2026 Report
TipRanks · 07/13 10:33
Senzime wins Brazil approval for TetraGraph neuromuscular monitor
TipRanks · 06/29 07:33
Senzime Launches TetraAnalytics to Expand TetraGraph Neuromuscular Monitoring Ecosystem
TipRanks · 06/05 08:33
Senzime Wins Major U.S. Pediatric Contract as New Data Backs Cost-Saving Anesthesia Monitoring
TipRanks · 06/03 10:03
Senzime launches more sustainable EMG sensor for TetraGraph anesthesia monitoring
TipRanks · 06/01 09:36
More
Webull provides a variety of real-time SNZZF stock news. You can receive the latest news about Senzime Ab through multiple platforms. This information may help you make smarter investment decisions.
About SNZZF
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.